Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $5.47 billion. The enterprise value is $5.28 billion.
Important Dates
The next estimated earnings date is Tuesday, November 25, 2025, after market close.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 138.26 million shares outstanding. The number of shares has increased by 12.88% in one year.
| Current Share Class | 138.26M |
| Shares Outstanding | 138.26M |
| Shares Change (YoY) | +12.88% |
| Shares Change (QoQ) | +3.39% |
| Owned by Insiders (%) | 3.91% |
| Owned by Institutions (%) | 69.84% |
| Float | 119.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.00 |
| Forward PS | 8.92 |
| PB Ratio | 10.46 |
| P/TBV Ratio | 10.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 250.31 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.87, with a Debt / Equity ratio of 1.37.
| Current Ratio | 4.87 |
| Quick Ratio | 4.67 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.31 |
Financial Efficiency
Return on equity (ROE) is -37.11% and return on invested capital (ROIC) is -6.66%.
| Return on Equity (ROE) | -37.11% |
| Return on Assets (ROA) | -5.96% |
| Return on Invested Capital (ROIC) | -6.66% |
| Return on Capital Employed (ROCE) | -9.10% |
| Revenue Per Employee | $940,847 |
| Profits Per Employee | -$243,706 |
| Employee Count | 609 |
| Asset Turnover | 0.51 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $1.97 million in taxes.
| Income Tax | 1.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.77% in the last 52 weeks. The beta is 1.14, so ARWR's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +96.77% |
| 50-Day Moving Average | 31.33 |
| 200-Day Moving Average | 20.07 |
| Relative Strength Index (RSI) | 67.49 |
| Average Volume (20 Days) | 1,790,589 |
Short Selling Information
The latest short interest is 11.65 million, so 8.43% of the outstanding shares have been sold short.
| Short Interest | 11.65M |
| Short Previous Month | 11.70M |
| Short % of Shares Out | 8.43% |
| Short % of Float | 9.74% |
| Short Ratio (days to cover) | 5.36 |
Income Statement
In the last 12 months, ARWR had revenue of $572.98 million and -$148.42 million in losses. Loss per share was -$1.14.
| Revenue | 572.98M |
| Gross Profit | 572.98M |
| Operating Income | -107.96M |
| Pretax Income | -157.39M |
| Net Income | -148.42M |
| EBITDA | -85.40M |
| EBIT | -107.96M |
| Loss Per Share | -$1.14 |
Full Income StatementBalance Sheet
The company has $898.17 million in cash and $713.29 million in debt, giving a net cash position of $184.89 million or $1.34 per share.
| Cash & Cash Equivalents | 898.17M |
| Total Debt | 713.29M |
| Net Cash | 184.89M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 519.81M |
| Book Value Per Share | 3.78 |
| Working Capital | 752.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $21.85 million and capital expenditures -$39.47 million, giving a free cash flow of -$17.62 million.
| Operating Cash Flow | 21.85M |
| Capital Expenditures | -39.47M |
| Free Cash Flow | -17.62M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -18.84% and -25.90%.
| Gross Margin | 100.00% |
| Operating Margin | -18.84% |
| Pretax Margin | -27.47% |
| Profit Margin | -25.90% |
| EBITDA Margin | -14.90% |
| EBIT Margin | -18.84% |
| FCF Margin | n/a |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.88% |
| Shareholder Yield | -12.88% |
| Earnings Yield | -2.71% |
| FCF Yield | -0.32% |
Dividend DetailsAnalyst Forecast
The average price target for ARWR is $47.75, which is 20.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.75 |
| Price Target Difference | 20.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 172.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 0.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.9 |
| Piotroski F-Score | 4 |
